Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness

  1. Oluwaseun Akeju  Is a corresponding author
  2. Marco L Loggia
  3. Ciprian Catana
  4. Kara J Pavone
  5. Rafael Vazquez
  6. James Rhee
  7. Violeta Contreras Ramirez
  8. Daniel B Chonde
  9. David Izquierdo-Garcia
  10. Grae Arabasz
  11. Shirley Hsu
  12. Kathleen Habeeb
  13. Jacob M Hooker
  14. Vitaly Napadow
  15. Emery Brown
  16. Patrick L Purdon
  1. Massachusetts General Hospital, Harvard Medical School, United States
  2. MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, United States
  3. Massachusetts General Hospital, United States
  4. Massachusetts Institute of Technology, United States

Abstract

Understanding the neural basis of consciousness is fundamental to neuroscience research. Disruptions in cortico-cortical connectivity have been suggested as a primary mechanism of unconsciousness. By using a novel combination of positron emission tomography and functional magnetic resonance imaging, we studied anesthesia-induced unconsciousness and recovery using the α2-agonist dexmedetomidine. During unconsciousness, cerebral metabolic rate of glucose and cerebral blood flow were preferentially decreased in the thalamus, the Default Mode Network (DMN), and the bilateral Frontoparietal Networks (FPNs). Cortico-cortical functional connectivity within the DMN and FPNs was preserved. However, DMN thalamo-cortical functional connectivity was disrupted. Recovery from this state was associated with sustained reduction in cerebral blood flow, and restored DMN thalamo-cortical functional connectivity. We report that loss of thalamo-cortical functional connectivity is sufficient to produce unconsciousness.

Article and author information

Author details

  1. Oluwaseun Akeju

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    For correspondence
    oluwaseun.akeju@mgh.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Marco L Loggia

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Ciprian Catana

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Kara J Pavone

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Rafael Vazquez

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. James Rhee

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Violeta Contreras Ramirez

    Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Daniel B Chonde

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. David Izquierdo-Garcia

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Grae Arabasz

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Shirley Hsu

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kathleen Habeeb

    Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Jacob M Hooker

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Vitaly Napadow

    MGH/MIT/HMS Athinoula A Martinos Center for Biomedical Imaging, Charlestown, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Emery Brown

    Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Patrick L Purdon

    Massachusetts Institute of Technology, Cambridge,, United States
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Human subjects: The Human Research Committee and the Radioactive Drug Research Committee at the Massachusetts General Hospital approved the study protocol. After an initial email/phone screen, potential study subjects were invited to participate in a screening visit. At the screening visit, informed consent including the consent to publish was requested after the nature and possible consequences of the study was explained. All subjects provided informed consent and were American Society of Anesthesiology Physical Status I with Mallampati Class I airway anatomy.

Copyright

© 2014, Akeju et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,515
    views
  • 689
    downloads
  • 139
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Oluwaseun Akeju
  2. Marco L Loggia
  3. Ciprian Catana
  4. Kara J Pavone
  5. Rafael Vazquez
  6. James Rhee
  7. Violeta Contreras Ramirez
  8. Daniel B Chonde
  9. David Izquierdo-Garcia
  10. Grae Arabasz
  11. Shirley Hsu
  12. Kathleen Habeeb
  13. Jacob M Hooker
  14. Vitaly Napadow
  15. Emery Brown
  16. Patrick L Purdon
(2014)
Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness
eLife 3:e04499.
https://doi.org/10.7554/eLife.04499

Share this article

https://doi.org/10.7554/eLife.04499

Further reading

    1. Neuroscience
    Jian Dong, Mian Chen ... Matthijs Verhage
    Research Article

    Dense core vesicles (DCVs) transport and release various neuropeptides and neurotrophins that control diverse brain functions, but the DCV secretory pathway remains poorly understood. Here, we tested a prediction emerging from invertebrate studies about the crucial role of the intracellular trafficking GTPase Rab10, by assessing DCV exocytosis at single-cell resolution upon acute Rab10 depletion in mature mouse hippocampal neurons, to circumvent potential confounding effects of Rab10’s established role in neurite outgrowth. We observed a significant inhibition of DCV exocytosis in Rab10-depleted neurons, whereas synaptic vesicle exocytosis was unaffected. However, rather than a direct involvement in DCV trafficking, this effect was attributed to two ER-dependent processes, ER-regulated intracellular Ca2+ dynamics, and protein synthesis. Gene Ontology analysis of differentially expressed proteins upon Rab10 depletion identified substantial alterations in synaptic and ER/ribosomal proteins, including the Ca2+ pump SERCA2. In addition, ER morphology and dynamics were altered, ER Ca2+ levels were depleted, and Ca2+ homeostasis was impaired in Rab10-depleted neurons. However, Ca2+ entry using a Ca2+ ionophore still triggered less DCV exocytosis. Instead, leucine supplementation, which enhances protein synthesis, largely rescued DCV exocytosis deficiency. We conclude that Rab10 is required for neuropeptide release by maintaining Ca2+ dynamics and regulating protein synthesis. Furthermore, DCV exocytosis appeared more dependent on (acute) protein synthesis than synaptic vesicle exocytosis.

    1. Neuroscience
    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.